| Title |
Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma
|
|---|---|
| Published in |
Cytogenetic and Genome Research, May 2008
|
| DOI | 10.1159/000134699 |
| Pubmed ID | |
| Authors |
S. Bekri, J. Adélaïde, S. Merscher, J. Grosgeorge, F. Caroli-Bosc, D. Perucca-Lostanlen, P.M. Kelley, M.-J. Pébusque, C. Theillet, D. Birnbaum, P. Gaudray |
| Abstract |
Amplification of loci present on band q13 of human chromosome 11 is a feature of a subset of estrogen receptor positive breast carcinomas prone to metastasis. As many as five distinct amplification units have been described on 11q13. They include particularly a genomic area encompassing the GARP gene at 11q13.5-->q14.1. We have reassessed our current knowledge of this region, located telomeric to CCND1 and EMS1, which is amplified in 7-10% of mammary tumors. The loose definition of the driving forces of these amplification events led us to map accurately the boundaries of the amplifiable region, and thus to contribute a physical and transcriptional map of a 3-Mb region of chromosome 11. Four new genes were placed on the regional map, namely CBP2, CLNS1A, UVRAG, and PAK1. We have narrowed the core of the 11q13-->q14 amplicon to a 350-kb area encompassing D11S533, mostly on its telomeric side. The map reported here represents an indispensable step toward sequencing the entire region, and thus toward uncovering gene(s) which play(s) a critical role in breast cancer progression. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 6 | 26% |
| Student > Ph. D. Student | 4 | 17% |
| Researcher | 4 | 17% |
| Student > Doctoral Student | 2 | 9% |
| Student > Bachelor | 2 | 9% |
| Other | 0 | 0% |
| Unknown | 5 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 6 | 26% |
| Biochemistry, Genetics and Molecular Biology | 5 | 22% |
| Medicine and Dentistry | 4 | 17% |
| Chemical Engineering | 1 | 4% |
| Computer Science | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 5 | 22% |